Cargando…

The receptor for advanced glycation end products and risk of peripheral arterial disease, amputation or death in type 2 diabetes: a population-based cohort study

BACKGROUND: Patients with type 2 diabetes have a high risk for early and extensive development of peripheral arterial disease (PAD) and this excess risk is not explained by increased burden of traditional atherosclerotic risk factors. Activation of the receptor for advanced glycation end products (R...

Descripción completa

Detalles Bibliográficos
Autores principales:	Malmstedt, Jonas, Kärvestedt, Lars, Swedenborg, Jesper, Brismar, Kerstin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4517412/ https://www.ncbi.nlm.nih.gov/pubmed/26216409 http://dx.doi.org/10.1186/s12933-015-0257-5

Ejemplares similares

A retrospective analysis of amputation rates in diabetic patients: can lower extremity amputations be further prevented?
por: Alvarsson, Alexandra, et al.
Publicado: (2012)

Peripheral Sensory Neuropathy Associates With Micro- or Macroangiopathy: Results from a population-based study of type 2 diabetic patients in Sweden
por: Kärvestedt, Lars, et al.
Publicado: (2009)

Assessment of Advanced Glycation End Products and Receptors and the Risk of Dementia
por: Chen, Jinluan, et al.
Publicado: (2021)

Association of Ankle-Brachial Indices With Limb Revascularization or Amputation in Patients With Peripheral Artery Disease
por: Moussa Pacha, Homam, et al.
Publicado: (2018)

The role of profilin-1 in endothelial cell injury induced by advanced glycation end products (AGEs)
por: Li, Zhenyu, et al.
Publicado: (2013)

Advanced glycation end-products decreases expression of endothelial nitric oxide synthase through oxidative stress in human coronary artery endothelial cells
por: Ren, Xiaomei, et al.
Publicado: (2017)

Advanced glycation end products impair the migration, adhesion and secretion potentials of late endothelial progenitor cells
por: Li, Hong, et al.
Publicado: (2012)

Novel Receptor for Advanced Glycation End Products‐Blocking Antibody to Treat Diabetic Peripheral Artery Disease
por: Johnson, Lynne L., et al.
Publicado: (2020)

Predictive value of advanced glycation end products for the development of post-infarction heart failure: a preliminary report
por: Raposeiras-Roubín, Sergio, et al.
Publicado: (2012)

Sildenafil Ameliorates Advanced Glycation End Products-Induced Mitochondrial Dysfunction in HT-22 Hippocampal Neuronal Cells
por: Sung, Soon Ki, et al.
Publicado: (2016)

Peripheral Stent Thrombosis Leading to Acute Limb Ischemia and Major Amputation: Incidence and Risk Factors in the Aortoiliac and Femoropopliteal Arteries
por: Katsanos, Konstantinos, et al.
Publicado: (2016)

Plasma levels of advanced glycation endproducts are associated with type 1 diabetes and coronary artery calcification
por: van Eupen, Marcelle GA, et al.
Publicado: (2013)

Evolution and bad prognostic value of advanced glycation end products after acute heart failure: relation with body composition
por: Paradela-Dobarro, Beatriz, et al.
Publicado: (2017)

Accumulation of advanced glycation end products (AGEs) is associated with the severity of aortic stenosis in patients with concomitant type 2 diabetes
por: Kopytek, Magdalena, et al.
Publicado: (2020)

Increased expression of the receptor for advanced glycation end-products in human peripheral neuropathies
por: Juranek, Judyta K, et al.
Publicado: (2013)

Increased proinflammatory endothelial response to S100A8/A9 after preactivation through advanced glycation end products
por: Ehlermann, Philipp, et al.
Publicado: (2006)

Relationship between Advanced Glycation End Products and Plaque Progression in Patients with Acute Coronary Syndrome: The JAPAN-ACS Sub-study
por: Fukushima, Yoshifumi, et al.
Publicado: (2013)

Advanced Glycation End Products and Psoriasis
por: Maurelli, Martina, et al.
Publicado: (2023)

Heparanase induced by advanced glycation end products (AGEs) promotes macrophage migration involving RAGE and PI3K/AKT pathway
por: Qin, Qiaojing, et al.
Publicado: (2013)

Neuronal cell death and regeneration in diseases associated with advanced glycation end-products accumulation
por: Bikbova, Guzel, et al.
Publicado: (2014)

Immunization with advanced glycation end products modified low density lipoprotein inhibits atherosclerosis progression in diabetic apoE and LDLR null mice
por: Zhu, Lin, et al.
Publicado: (2014)

Advanced glycation end products induce brain-derived neurotrophic factor release from human platelets through the Src-family kinase activation
por: Furukawa, Kazuo, et al.
Publicado: (2017)

Glycated albumin is more closely correlated with coronary artery disease than 1,5-anhydroglucitol and glycated hemoglobin A1c
por: Ma, Xiaojing, et al.
Publicado: (2015)

Advanced glycation end-products, measured as skin autofluorescence, associate with vascular stiffness in diabetic, pre-diabetic and normoglycemic individuals: a cross-sectional study
por: Birukov, Anna, et al.
Publicado: (2021)

Dietary Advanced Glycation End Products and Aging
por: Luevano-Contreras, Claudia, et al.
Publicado: (2010)

Advanced Glycation End Products and Diabetic Complications
por: Singh, Varun Parkash, et al.
Publicado: (2014)

Advanced Glycation End Products in the Pathogenesis of Psoriasis
por: Papagrigoraki, Anastasia, et al.
Publicado: (2017)

Toxicity of advanced glycation end products (Review)
por: Kuzan, Aleksandra
Publicado: (2021)

Advanced Glycation End Products in Health and Disease
por: Reddy, V. Prakash, et al.
Publicado: (2022)

The Role of Advanced Glycation End Products on Dyslipidemia
por: Vekic, Jelena, et al.
Publicado: (2023)

Advanced Glycation End Products and Oxidative Stress in Type 2 Diabetes Mellitus
por: Nowotny, Kerstin, et al.
Publicado: (2015)

Advanced glycation end products potentiate citrated plasma-evoked oxidative and inflammatory reactions in endothelial cells by up-regulating protease-activated receptor-1 expression
por: Ishibashi, Yuji, et al.
Publicado: (2014)

Impact of intracellular glyceraldehyde-derived advanced glycation end-products on human hepatocyte cell death
por: Sakasai-Sakai, Akiko, et al.
Publicado: (2017)

Impact of intracellular toxic advanced glycation end-products (TAGE) on murine myoblast cell death
por: Takata, Takanobu, et al.
Publicado: (2020)

Critical Role for the Advanced Glycation End‐Products Receptor in Pulmonary Arterial Hypertension Etiology
por: Meloche, Jolyane, et al.
Publicado: (2013)

Glycosylated hemoglobin, but not advanced glycation end products, predicts severity of coronary artery disease in patients with or without diabetes
por: Basman, Craig, et al.
Publicado: (2020)

Advanced glycation end products induce chemokine/cytokine production via activation of p38 pathway and inhibit proliferation and migration of bone marrow mesenchymal stem cells
por: Yang, Ke, et al.
Publicado: (2010)

Hesperetin treatment attenuates glycation of lens proteins and advanced‑glycation end products generation
por: Doki, Yuri, et al.
Publicado: (2023)

Molecularly targeted nanoparticles: an emerging tool for evaluation of expression of the receptor for advanced glycation end products in a murine model of peripheral artery disease
por: Woźniak, Marcin, et al.
Publicado: (2021)

Risks of Nontraumatic Lower-Extremity Amputations in Patients with Type 1 Diabetes: A population-based cohort study in Sweden
por: Jonasson, Junmei Miao, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_vhts31ektrjngp9t4nck7taqhs